Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

aTYR PHARMA (ATYR) Other Gross PP&E Adjustments (2019 - 2025)

aTYR PHARMA's Other Gross PP&E Adjustments history spans 7 years, with the latest figure at $6.1 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 1.73% year-over-year to $6.1 million; the TTM value through Dec 2025 reached $6.1 million, down 1.73%, while the annual FY2025 figure was $6.1 million, 1.73% down from the prior year.
  • Other Gross PP&E Adjustments reached $6.1 million in Q4 2025 per ATYR's latest filing, up from -$5.6 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $6.5 million in Q4 2022 to a low of -$7.1 million in Q2 2023.
  • Average Other Gross PP&E Adjustments over 5 years is -$1.3 million, with a median of -$1.3 million recorded in 2021.
  • Peak YoY movement for Other Gross PP&E Adjustments: plummeted 786.98% in 2023, then skyrocketed 284.98% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $4.1 million in 2021, then soared by 60.85% to $6.5 million in 2022, then tumbled by 75.46% to $1.6 million in 2023, then surged by 284.98% to $6.2 million in 2024, then fell by 1.73% to $6.1 million in 2025.
  • Per Business Quant, the three most recent readings for ATYR's Other Gross PP&E Adjustments are $6.1 million (Q4 2025), -$5.6 million (Q3 2025), and -$894000.0 (Q2 2025).